NEW YORK (GenomeWeb News) – Bruker reported today that its revenues in the third quarter were down 4 percent year over year, falling to $419.8 million from $439 million in Q3 2013.

It missed analysts' consensus estimates on the top and bottom line, leading to a 12 percent decline in its share price to $18.35 in early Friday trade on the Nasdaq.

The drop in revenues was driven by weakness in demand for the company's NMR, semiconductor, and data storage products, President and CEO Frank Laukien said on a conference call following the earnings release.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Researchers have sequenced the northern white rhinoceros to gauge whether it could be brought back from the edge of extinction, the New York Times reports.

Bavaria expands its forensic genetic analyses to include DNA phenotyping, raising discrimination concerns.

Tufts University researchers found a role for miRNA in transmitting stress between generations, the Economist reports.

In Science this week: gut microbiome influences liver cancer growth, spread; and more.

Sponsored by
Advanced Cell Diagnostics

This webinar will provide evidence for the use of RNA in situ hybridization (RNA ISH) as a replacement for immunohistochemistry (IHC) in cancer research and diagnostic applications.